Tenet Healthcare Stock
Price
Target price
€119.00
€119.00
0.850%
-
0.850%
€124.47
17.05.24 / Tradegate
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Stock / Healthcare Providers & Services / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Tenet Healthcare Stock
Tenet Healthcare gained 0.850% compared to yesterday.
The stock is an absolute favorite of our community with 28 Buy predictions and no Sell predictions.
As a result the target price of 124 € shows a slightly positive potential of 4.2% compared to the current price of 119.0 € for Tenet Healthcare.
Pros and Cons of Tenet Healthcare in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tenet Healthcare vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tenet Healthcare | 0.850% | 1.709% | 32.222% | 84.496% | 72.464% | 122.181% | 536.364% |
| Amn Healthcare Svs | - | -3.604% | 2.885% | -38.857% | -20.149% | -26.207% | 19.942% |
| Ensign Group Inc. | 0.910% | 0.917% | 0.000% | - | 6.796% | - | - |
| Select Medical Holdings | -2.480% | 1.282% | - | - | - | - | - |
Comments
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $113.00 to $147.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $109.00 to $136.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at UBS Group AG from $137.00 to $150.00. They now have a "buy" rating on the stock.
Show more
Ratings data for THC provided by MarketBeat
